Medicare Enrolled
Dr. Maria Voznesensky, MD
Urology Physician · Albany, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Voznesensky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Voznesensky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Voznesensky
Dr. Maria Voznesensky is an urology physician in Albany, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Voznesensky performed 879 Medicare services across 747 unique beneficiaries.
Between the years covered by Open Payments, Dr. Voznesensky received a total of $11,055 from 52 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Voznesensky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ 879 Medicare services
$11,055 industry payments
Medicare Practice Summary
Medicare Utilization ↗879
Medicare services
Bottom 44% in NY for urology physician
747
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~55 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
219 | $94 | $231 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
150 | $168 | $321 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
92 | $102 | $310 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
74 | $62 | $150 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
49 | $3 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $70 | $173 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
38 | $8 | $37 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $123 | $367 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
32 | $19 | $50 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
29 | $558 | $1,687 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
22 | $12 | $35 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
22 | $25 | $57 |
| Bladder emptying assessment A timed evaluation to measure how effectively the bladder empties urine. |
17 | $5 | $30 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
17 | $70 | $136 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $96 | $1,224 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
12 | $286 | $832 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
11 | $201 | $577 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
13.0% medium
84.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,055
Total received (2018-2024)
Avg $1,579/year across 7 years
Top 17% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,963 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$92 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,264
2023
$1,156
2022
$787
2021
$1,765
2020
$382
2019
$3,844
2018
$1,857
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$209
Boston Scientific Corporation
$155
Axonics, Inc.
$149
Merck Sharp & Dohme LLC
$139
ABBVIE INC.
$118
Ferring Pharmaceuticals Inc.
$56
PROCEPT BioRobotics Corporation
$50
COLOPLAST CORP
$49
Endo USA, Inc.
$48
Endo Pharmaceuticals Inc.
$46
UROGEN PHARMA, INC.
$42
Teleflex LLC
$41
Janssen Biotech, Inc.
$31
Astellas Pharma US Inc
$27
180 Medical, Inc.
$19
PFIZER INC.
$18
Medtronic, Inc.
$18
Olympus America Inc.
$17
Sumitomo Pharma America, Inc.
$16
ACCORD HEALTHCARE, INC.
$15
Top 3 companies account for 40.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$3,207
Medtronic USA, Inc.
$1,664
BOSTON SCIENTIFIC CORPORATION
$1,243
Astellas Pharma US Inc
$939
UroGen Pharma, Inc.
$329
PROCEPT BioRobotics Corporation
$327
Allergan Inc.
$249
Myriad Genetic Laboratories, Inc.
$239
Merck Sharp & Dohme LLC
$213
Endo Pharmaceuticals Inc.
$202
Axonics, Inc.
$199
ABBVIE INC.
$190
Avadel Specialty Pharmaceuticals, LLC
$186
NeoTract Inc.
$185
AbbVie Inc.
$176
Janssen Biotech, Inc.
$136
Caldera Medical, Inc
$129
UROVANT SCIENCES INC
$94
180 Medical, Inc.
$92
Allergan, Inc.
$70
Ferring Pharmaceuticals Inc.
$67
PFIZER INC.
$63
COLOPLAST CORP
$61
Endo USA, Inc.
$48
Photocure Inc
$47
KARL STORZ Endoscopy-America
$47
Antares Pharma, Inc.
$44
UROGEN PHARMA, INC.
$42
Sumitomo Pharma America, Inc.
$42
Teleflex LLC
$41
Dendreon Pharmaceuticals LLC
$39
Tolmar, Inc.
$37
Coloplast Corp
$35
Integra LifeSciences Corporation
$32
Olympus America Inc.
$32
TOLMAR Pharmaceuticals, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$28
Blue Earth Diagnostics Limited
$21
Kowa Pharmaceuticals America, Inc.
$20
Myovant Sciences Inc.
$18
Hollister Incorporated
$18
Merck Sharp & Dohme Corporation
$18
Medtronic, Inc.
$18
C. R. BARD, INC. & SUBSIDIARIES
$17
Alnylam Pharmaceuticals Inc.
$16
Supernus Pharmaceuticals, Inc.
$16
ABC Home Medical Supply, Inc.
$16
AstraZeneca Pharmaceuticals LP
$16
ACCORD HEALTHCARE, INC.
$15
Rochester Medical Corporation
$15
Monaghan Medical Corporation
$13
Prometheus Laboratories Inc.
$11
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 8.5 FR. X 700MM · ADSTILADRIN · ADVANTAGE FIT · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Aerobika · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · CMOS VIDEO URETEROSCOPE · Cysview · Desara · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL FEMALE SUI · GENERAL ERECTILE DYSFUNCTION · GENERAL PELVIC ORGAN PROLAPSE · GENERAL - ERECTILE DYSFUNCTION · GENERAL - FEMALE SUI · GENERAL BPH · GIVLAARI · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LYNX · Luja Coude · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · OMNIGRAFT · ORGOVYX · PELVIC FLOOR REPAIR · PROLARIS · PROVENGE · Prolaris · Proleukin · Rezum Generator · SEGLENTIS · Solyx SIS System · SpaceOAR VUE System - 10mL · SpeediCath · UROLIFT · UroLift · VaPro · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
44
Per 100K population
14.0
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Voznesensky is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of NY peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Voznesensky experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Voznesensky performed 219 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Voznesensky receive payments from pharmaceutical companies?
Yes. Dr. Voznesensky received a total of $11,055 from 52 companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Voznesensky's costs compare to other urology physicians in Albany?
Dr. Voznesensky's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Voznesensky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Albany
Browse urology physicians in Albany ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology